Alexander J. Glass
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Alexander J. Glass
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
11
| Private Company | Miscellaneous Commercial Services | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Alexander J. Glass
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman | |
ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
NEUROBIOLOGICAL TECHNOLOGIES, INC. | Biotechnology | Chief Executive Officer | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder | |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
Ascalon International, Inc.
Ascalon International, Inc. BiotechnologyHealth Technology Ascalon International, Inc. develops oncology drugs. The company was founded by Keith Benson on February 24, 2010 and is headquartered in Scottsdale, AZ. | Biotechnology | Corporate Officer/Principal | |
Active Life Scientific, Inc.
Active Life Scientific, Inc. Medical SpecialtiesHealth Technology Active Life Scientific, Inc. operates as a medical technology company that develops a device for measuring bone strength. Its BioDent is a reference point indenter for use in various applications that include lab and clinical research of bone fracture risk and effects of osteoporosis treatments and diagnosis and treatment of musculoskeletal diseases and disorders. The company was founded by Davis Brimer, Paul Hansma and Alexander Proctor in July 2007 and is headquartered in Santa Barbara, CA. | Medical Specialties | Director/Board Member | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree | |
University of Sunderland | College/University | Doctorate Degree | |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Rensselaer Polytechnic Institute | College/University | Masters Business Admin | |
University of California, Berkeley | College/University | Undergraduate Degree | |
Indian Institute of Science | College/University | Doctorate Degree | |
University of Mumbai | College/University | Graduate Degree | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
University of Geneva | College/University | Graduate Degree | |
Max-Planck-Institute for Molecular Genetics | College/University | Chief Tech/Sci/R&D Officer | |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded in March 1991 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member Public Communications Contact | |
VAXCYTE, INC. | Biotechnology | Director/Board Member | |
C2N Diagnostics LLC
C2N Diagnostics LLC BiotechnologyHealth Technology C2N Diagnostics LLC is a private company that focuses on mechanism-based approaches to prevent or stop the progression of human neurological disorders. The company is based in St. Louis, MO. The company's lead commercial product, PrecivityAD™, is a mass spectrometry-based test that measures in blood multiple analytes including a?42, a?40, and apolipoprotein e isoforms. This test predicts brain amyloid plaques as determined by PET scan results and received a breakthrough device designation from the Food and Drug Administration in early 2019. C2N Diagnostics aims to bring accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring in the field of neurodegeneration and Alzheimer's disease. The company was founded by Ravi Kiron, Joel Bennett Braunstein, Ilana Fogelman. Joel Bennett Braunstein has been the CEO since incorporation. | Biotechnology | Founder | |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman | |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | President | |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Pharmaceuticals: Major | Chief Executive Officer | |
ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Adjuvant Partners LLC | Corporate Officer/Principal | ||
TRex Bio Ltd.
TRex Bio Ltd. BiotechnologyHealth Technology TRex Bio Ltd. is a British company that provides biotechnology research and development services. The private company is based in London, UK. The company was founded in 2018 by Houman Ashrafian. | Biotechnology | Director/Board Member | |
IO BIOTECH, INC. | Biotechnology | Chairman |
Statistik
International
Vereinigte Staaten | 37 |
Vereinigtes Königreich | 5 |
Deutschland | 4 |
Indien | 3 |
Dänemark | 3 |
Sektoral
Health Technology | 35 |
Consumer Services | 10 |
Commercial Services | 4 |
Finance | 4 |
Operativ
Director/Board Member | 50 |
Corporate Officer/Principal | 45 |
Independent Dir/Board Member | 18 |
President | 14 |
Director of Finance/CFO | 12 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Robert Stein | 34 |
Charles Casamento | 27 |
Bob E. Curry | 19 |
K. Hirth | 18 |
Ravi Kiron | 11 |
Matthew M. Loar | 9 |
Henry C. Settle | 9 |
Patrick James Doyle | 8 |
Irwin A. Heyman | 8 |
Karen Carothers | 8 |
Timothy L. Enns | 7 |
- Börse
- Insiders
- Alexander J. Glass
- Unternehmensverbindungen